|

DPA-714-PET/MRI Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • University of Alabama at Birmingham2

Indications

  • Parkinson's Disease1
  • Fibromyalgia1
  • Chronic Fatigue Syndrome1
  • Parkinson Disease1
  • Multiple Sclerosis1

Birmingham, Alabama2 trials

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

University of Alabama at Birmingham Medical Center

Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

UAB Advanced Imaging Facility

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.